ScholarLink (思领科)
错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2024年6月3日

查看全文
  • Toufik Kamel,
  • Ralf Janssen-Langenstein,
  • Quentin Quelven,
  • Jonathan Chelly,
  • Xavier Valette,
  • Minh-Pierre Le,
  • Jeremy Bourenne,
  • Denis Garot,
  • Pierre Fillatre,
  • Marie Labruyere,
  • Nicholas Heming,
  • Fabien Lambiotte,
  • Jean-Baptiste Lascarrou,
  • Olivier Lesieur,
  • Konstantinos Bachoumas,
  • Alexis Ferre,
  • Eric Maury,
  • Ludivine Chalumeau-Lemoine,
  • David Bougon,
  • Damien Roux,
  • Olivier Guisset,
  • Remi Coudroy,
  • Thierry Boulain,
  • Auchabie Johann,
  • Beuret Pascal,
  • Darreau Cédric,
  • Desmeulles Isabelle,
  • Guervilly Christophe,
  • Hong Tuan Ha Vivien,
  • Jochmans Sébastien,
  • Jozwiak Mathieu,
  • Louis Guillaume,
  • Navellou Jean-Christophe,
  • Neuville Mathilde,
  • Pichon Nicolas,
  • Sagnier Anne,
  • Schnell David

摘要

Purpose

Severe Pneumocystis jirovecii pneumonia (PJP) requiring intensive care has been the subject of few prospective studies. It is unclear whether delayed curative antibiotic therapy may impact survival in these severe forms of PJP. The impact of corticosteroid therapy combined with antibiotics is also unclear.

Methods

This multicentre, prospective observational study involving 49 adult intensive care units (ICUs) in France was designed to evaluate the severity, the clinical spectrum, and outcomes of patients with severe PJP, and to assess the association between delayed curative antibiotic treatment and adjunctive corticosteroid therapy with mortality.

Results

We included 158 patients with PJP from September 2020 to August 2022. Their main reason for admission was acute respiratory failure (n = 150, 94.9%). 12% of them received antibiotic prophylaxis for PJP before ICU admission. The ICU, hospital, and 6-month mortality were 31.6%, 35.4%, and 40.5%, respectively. Using time-to-event analysis with a propensity score-based inverse probability of treatment weighting, the initiation of curative antibiotic treatment after 96 h of ICU admission was associated with faster occurrence of death [time ratio: 6.75; 95% confidence interval (95% CI): 1.48–30.82; P = 0.014]. The use of corticosteroids for PJP was associated with faster occurrence of death (time ratio: 2.48; 95% CI 1.01–6.08; P = 0.048).

Conclusion

This study showed that few patients with PJP admitted to intensive care received prophylactic antibiotic therapy, that delay in curative antibiotic treatment was common and that both delay in curative antibiotic treatment and adjunctive corticosteroids for PJP were associated with accelerated mortality.